Cascade testing in an ovarian cancer traceback genetic testing program: The GRACE study experience
{{output}}
Approximately 20% of individuals diagnosed with ovarian cancer (OC) have an inherited pathogenic or likely pathogenic variant (P/LP) in a cancer risk gene. Though genetic testing for hereditary cancer risk is currently recommended at OC diagnosis, individuals ... ...
